retatrutide type 2 diabetes phase 2 results 2024 The numbers from Lilly's 3 trial dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user Pharmacological therapies for type 2

Session 1 After informed consent was obtained, participants completed a Timeline Follow Back (TLFB) to measure drinking in the past 30 days, Patient Health Questionnaire (PHQ-9), and a medical interview which asked about current and past medication history and other medical history to ensure safe participation in the study, as reviewed by a study physician

The key to smooth customs clearance is proactive documentation, not reactive problem-solving

Recent Findings Observational studies and continuous glucose monitoring (CGM) reports reveal a high prevalence of hypoglycemia in post-bariatric pregnancies, ranging from 50% to 58%

A short course of a mild topical corticosteroid may be recommended by a clinician if appropriate